An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score

被引:905
|
作者
Frank, I [1 ]
Blute, ML
Cheville, JC
Lohse, CM
Weaver, AL
Zincke, H
机构
[1] Mayo Med Sch & Mayo Clin, Dept Urol, Rochester, MN 55905 USA
[2] Mayo Med Sch & Mayo Clin, Dept Pathol, Rochester, MN USA
[3] Mayo Med Sch & Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源
JOURNAL OF UROLOGY | 2002年 / 168卷 / 06期
关键词
carcinoma; renal cell; treatment outcome; survival; nephrectomy;
D O I
10.1016/S0022-5347(05)64153-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Currently outcome prediction in renal cell carcinoma is largely based on pathological stage and tumor grade. We developed an outcome prediction model for patients treated with radical nephrectomy for clear cell renal cell carcinoma, which was based on all available clinical and pathological features significantly associated with death from renal cell carcinoma. Materials and Methods: We identified 1,801 adult patients with unilateral clear cell renal cell carcinoma treated with radical nephrectomy between 1970 and 1998. Clinical features examined included age, sex, smoking history, and signs and symptoms at presentation. Pathological features examined included 1997 TNM stage, tumor size, nuclear grade, histological tumor necrosis, sarcomatoid component, cystic architecture, multifocality and surgical margin status. Cancer specific survival was estimated using the Kaplan-Meier method. Cox proportional hazards regression models were used to test associations between features studied and outcome. The selection of features included in the multivariate model was validated using bootstrap methodology. Results: Mean followup was 9.7 years (range 0.1 to 3 1). Estimated cancer specific survival rates at 1, 3, 5, 7 and 10 years were 86.6%, 74.0%, 68.7%, 63.8% and 60.0%, respectively. Several features were multivariately associated with death from clear cell renal cell carcinoma, including 1997 TNM stage (p <0.001), tumor size 5 cm. or greater (p <0.001), nuclear grade (p <0.001) and histological tumor necrosis (p <0.001). Conclusions: In patients with clear cell renal cell carcinoma 1997 TNM stage, tumor size, nuclear grade and histological tumor necrosis were significantly associated with cancer specific survival. We present a scoring system based on these features that can be used to predict outcome.
引用
收藏
页码:2395 / 2400
页数:6
相关论文
共 50 条
  • [1] Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: The D-SSIGN score
    Houston Thompson, R.
    Leibovich, Bradley C.
    Lohse, Christine M.
    Cheville, John C.
    Zincke, Horst
    Blute, Michael L.
    Frank, Igor
    [J]. JOURNAL OF UROLOGY, 2007, 177 (02): : 477 - 480
  • [2] Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
    Parker, William P.
    Cheville, John C.
    Frank, Igor
    Zaid, Harras B.
    Lohse, Christine M.
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Thompson, R. Houston
    [J]. EUROPEAN UROLOGY, 2017, 71 (04) : 665 - 673
  • [3] Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy
    Frank, I
    Leibovich, BC
    Lohse, CM
    Cheville, JC
    Zincke, H
    Blute, ML
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 28 - 28
  • [4] Preoperative prediction of the stage, size, grade, and necrosis score in clear cell renal cell carcinoma using MRI-based radiomics
    Choi, Ji Whae
    Hu, Rong
    Zhao, Yijun
    Purkayastha, Subhanik
    Wu, Jing
    McGirr, Aidan J.
    Stavropoulos, S. William
    Silva, Alvin C.
    Soulen, Michael C.
    Palmer, Matthew B.
    Zhang, Paul J. L.
    Zhu, Chengzhang
    Ahn, Sun Ho
    Bai, Harrison X.
    [J]. ABDOMINAL RADIOLOGY, 2021, 46 (06) : 2656 - 2664
  • [5] Preoperative prediction of the stage, size, grade, and necrosis score in clear cell renal cell carcinoma using MRI-based radiomics
    Ji Whae Choi
    Rong Hu
    Yijun Zhao
    Subhanik Purkayastha
    Jing Wu
    Aidan J. McGirr
    S. William Stavropoulos
    Alvin C. Silva
    Michael C. Soulen
    Matthew B. Palmer
    Paul J. L. Zhang
    Chengzhang Zhu
    Sun Ho Ahn
    Harrison X. Bai
    [J]. Abdominal Radiology, 2021, 46 : 2656 - 2664
  • [6] Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer
    El Khoury, Louis Y.
    Fu, Shuang
    Hlady, Ryan A.
    Wagner, Ryan T.
    Wang, Liguo
    Eckel-Passow, Jeanette E.
    Castle, Erik P.
    Stanton, Melissa L.
    Thompson, R. Houston
    Parker, Alexander S.
    Ho, Thai H.
    Robertson, Keith D.
    [J]. CLINICAL EPIGENETICS, 2021, 13 (01)
  • [7] Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer
    Louis Y. El Khoury
    Shuang Fu
    Ryan A. Hlady
    Ryan T. Wagner
    Liguo Wang
    Jeanette E. Eckel-Passow
    Erik P. Castle
    Melissa L. Stanton
    R. Houston Thompson
    Alexander S. Parker
    Thai H. Ho
    Keith D. Robertson
    [J]. Clinical Epigenetics, 2021, 13
  • [8] The mayo clinic stage, size, grade and necrosis (SSIGN) score for clear cell renal cell carcinoma: External validation by a single European centre applying routine pathology
    Zigeuner, R.
    Hutterer, G.
    Chromecki, T.
    Kampel-Kettner, K.
    Imamovic, A.
    Langner, C.
    Rehak, P.
    Pummer, K.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 280 - 280
  • [9] The impact of tumor size on clinical outcome in patients with localized renal cell carcinoma treated by radical nephrectomy
    Nativ, O
    Sabo, E
    Raviv, G
    Madjar, S
    Halachmi, S
    Moskovitz, B
    [J]. JOURNAL OF UROLOGY, 1997, 158 (03): : 729 - 732
  • [10] External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
    Zigeuner, Richard
    Hutterer, Georg
    Chromecki, Thomas
    Imamovic, Arvin
    Kampel-Kettner, Karin
    Rehak, Peter
    Langner, Cord
    Pummer, Karl
    [J]. EUROPEAN UROLOGY, 2010, 57 (01) : 102 - 109